Loading clinical trials...
Loading clinical trials...
A Randomised Phase II Study Of Nintedanib (BIBF1120) Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium
Conditions
Interventions
Nintedanib
Paclitaxel
+4 more
Locations
17
United Kingdom
Beatson West of Scotland Cancer Centre
Glasgow, Lanarkshire, United Kingdom
Ninewells Hospital
Dundee, Tayside, United Kingdom
Clatterbridge Cancer Centre
Liverpool, Wirral, United Kingdom
Belfast City Hospital (Northern Ireland Cancer Centre)
Belfast, United Kingdom
Bristol Heamatology and Cancer Centre
Bristol, United Kingdom
Velindre Hospital
Cardiff, United Kingdom
Start Date
April 1, 2015
Primary Completion Date
March 1, 2020
Completion Date
March 1, 2021
Last Updated
August 15, 2016
NCT05281471
NCT06065462
NCT04104776
NCT05226507
NCT05415098
NCT00025467
Lead Sponsor
NHS Greater Glasgow and Clyde
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions